Magnetic Resonance - Technology Information Portal Welcome to MRI Technology
Info
  Sheets


Out-
      side
 



 
 'Permeability' 
SEARCH FOR    
 
  2 3 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Result : Searchterm 'Permeability' found in 1 term [] and 14 definitions []
1 - 5 (of 15)     next
Result Pages : [1]  [2 3]
Searchterm 'Permeability' was also found in the following services: 
spacer
Forum  (1)  
 
Permeability
 
(m) Tendency of a substance to concentrate magnetic field, m = B/H.
spacer
 
• Share the entry 'Permeability':  Facebook  Twitter  LinkedIn  

• View the NEWS results for 'Permeability' (1).Open this link in a new window.
 
Further Reading:
  News & More:
MICRO-STRUCTURAL QUANTITIES - DIFFUSION, MAGNETISATION DECAY, MAGNETISATION TRANSFER AND PERMEABILITY(.pdf)
   by www.dundee.ac.uk    
Magnetic resonance-guided motorized transcranial ultrasound system for blood-brain barrier permeabilization along arbitrary trajectories in rodents
Thursday, 24 December 2015   by www.ncbi.nlm.nih.gov    
Quantitative MRI may differentiate true from pseudoprogression in glioblastoma
Saturday, 25 October 2014   by www.2minutemedicine.com    
Searchterm 'Permeability' was also found in the following services: 
spacer
Radiology  (3) Open this link in a new windowUltrasound  (1) Open this link in a new window
Magnetic Shielding
 
Means to confine the region of strong magnetic field surrounding a magnet;; most commonly the use of material with high permeability (passive shielding) or by employing secondary counteracting coils outside of the primary coils (active shielding). The high permeability material can be employed in the form of a yoke immediately surrounding the magnet (self-shielding) or installed in the walls of a room as full or partial room-shielding. Unlike shielding ionizing radiation, for example, magnetic shielding can only be accomplished by forcing the unavoidable magnetic return flux through more confined areas or structures, not by absorbing it.
See also Radio Frequency Shielding Radio Frequency Shielding, and Faraday cage.

See also the related poll result: 'Most outages of your scanning system are caused by failure of'
spacer

• View the DATABASE results for 'Magnetic Shielding' (11).Open this link in a new window

 
Further Reading:
  Basics:
Faraday's Law
   by hyperphysics.phy-astr.gsu.edu    
  News & More:
Magnetic Sensitivity of MRI Systems to External Iron: The Design Process
   by www.integratedsoft.com    
MRI Resources 
Shoulder MRI - PACS - Image Quality - Collections - Cochlear Implant - Implant and Prosthesis
 
NC100150 InjectionInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
Short name: NC100150, PEG-feron, generic name: Feruglose, preliminary trade name: Clariscan™
NC100150 injection is the code name for an USPIO (ultrasmall superparamagnetic iron oxide) MRI contrast agent under development. Microvessel permeability depends on functional and morphologic characteristics of cancer vessels and on physicochemical properties of the injected contrast medium molecule.
USPIO particles have a favorable pharmacological and tolerance profile and are being tested clinically of the potential for the quantitative characterization of tumor microvasculature and specifically for measures of the microvessel permeability. Iron-based products take advantage of their large molecular size, which prevents diffusion into body tissues. These agents are disposed of by the liver and spleen as particulate matter.
NC100150 Injection (Nycomed Amersham, Amersham Health ) consists of USPIO particles that are composed of single crystals (4- to 7-nm diameter) and stabilized with a carbohydrate polyethylene glycol (PEG) coat. The iron oxide particles have to be suspended in an isotonic glucose solution. The final diameter of an USPIO particle is approximately 20 nm. Blood pool half-life is more than two hours in humans; the particles are taken up by the mononuclear phagocyte system and distributed mainly to the liver and spleen.
NC100150 would compete with the contrast agents Ferumoxytol from AMAG Pharmaceuticals, Inc. and Vasovist™ from EPIX Pharmaceuticals, Inc., but at this time the development of NC100150 Injection/Clariscan™ is discontinued.
spacer

• View the DATABASE results for 'NC100150 Injection' (5).Open this link in a new window


• View the NEWS results for 'NC100150 Injection' (2).Open this link in a new window.
Searchterm 'Permeability' was also found in the following services: 
spacer
Forum  (1)  
 
Breast MRIMRI Resource Directory:
 - Breast MRI -
 
(MR mammography) Magnetic resonance imaging of the breast is particularly useful in evaluation of newly diagnosed breast cancer, in women whose breast tissue is mammographically very dense and for screening in women with a high lifetime risk of breast cancer because of their family history or genetic disposition.
Breast MRI can be performed on all standard whole body magnets at a field strength of 0.5 T - 1.5 Tesla. Powerful gradient strengths over 15 mT/m will help to improve the balance between spatial resolution, scanning speed, and volume coverage. The use of a dedicated bilateral breast coil is obligatory.
Malignant lesions release angiogenic factors that increase local vessel density and vessel permeability. Breast cancer is detectable due to the strong enhancement in dynamic breast imaging that peaks early (about 1-2 min.) after contrast medium injection. If breast cancer is suspected, a breast biopsy may be necessary to secure the diagnosis.
See also Magnetic Resonance Imaging MRI, Biopsy and MR Guided Interventions.

Requirements in breast MRI procedures:
Both breasts must be measured without gaps.
Temporal resolution should be sufficient to allow early imaging after contrast agent with dynamic imaging every 60-120 sec.
For the best possible detection of enhancement fat signal should be eliminated either by image subtraction or by spectrally selective fat saturation.
Thin slices are necessary to assure absence of partial volume effects.
Imaging should be performed with a spatial resolution in plane less than 1 mm.


For Ultrasound Imaging (USI) see Breast Ultrasound at US-TIP.com.

See also the related poll result: 'MRI will have replaced 50% of x-ray exams by'
 
Images, Movies, Sliders:
 Breast MRI Images T2 And T1  Open this link in a new window
      
 Breast MRI Images T2 And T1 Pre - Post Contrast  Open this link in a new window
 Breast MRI Images T1 Pre - Post Contrast  Open this link in a new window
      
 
Radiology-tip.comMammography,  Breast Imaging
spacer
Radiology-tip.comBreast Ultrasound
spacer

• View the DATABASE results for 'Breast MRI' (13).Open this link in a new window


• View the NEWS results for 'Breast MRI' (41).Open this link in a new window.
 
Further Reading:
  Basics:
New Screening Guidelines for Women at High Risk for Breast Cancer
Wednesday, 26 September 2007   by www.newswise.com    
CONTRAST-ENHANCED MRI OF THE BREAST(.pdf)
MRI Improves Breast Cancer Screening in Older BRCA Carriers
Monday, 5 January 2015   by www.cancernetwork.com    
  News & More:
Researchers to develop new hybrid PET/MRI system for improved breast cancer diagnosis
Wednesday, 27 January 2016   by cordis.europa.eu    
Additional Breast Cancer Tumors Found on MRI After Mammography May Be Larger, More Aggressive
Wednesday, 9 December 2015   by www.oncologynurseadvisor.com    
Preoperative MRI May Overdiagnose Contralateral Breast Cancer
Wednesday, 2 December 2015   by www.cancertherapyadvisor.com    
MRI Better Detects Recurrent Breast Cancer
Friday, 15 August 2014   by www.doctorslounge.com    
7-Tesla MRI scanner allows even more accurate diagnosis of breast cancer
Thursday, 6 March 2014   by www.healthcanal.com    
BI-RADS and breast MRI useful in predicting malignancy
Wednesday, 30 May 2012   by www.oncologynurseadvisor.com    
Searchterm 'Permeability' was also found in the following services: 
spacer
Radiology  (3) Open this link in a new windowUltrasound  (1) Open this link in a new window
Clariscan™InfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
An iron-based contrast agent with large molecular size, which prevents diffusion into body tissues and will be developed for MR imaging of the liver (taken up by macrophages), tumor microvasculature and microvessel permeability. The blood half live of the particles with 11-20 nm diameter is 3-4 hours.
At this time the development of Clariscan™ is discontinued.
See also NC100150 Injection and Ultrasmall Superparamagnetic Iron Oxide.

Drug Information and Specification
NAME OF COMPOUND Feruglose, PEG-feron, USPIO, NC100150
DEVELOPER Amersham Health
CENTRAL MOIETY Fe
CONTRAST EFFECT T2, Predominantly negative enhancement
RELAXIVITY R1=20, R2=35, B0=0.5T
PHARMACOKINETIC Intravascular
OSMOLALITY
CONCENTRATION 29.8 mg Fe/mL
PREPARATION Suspend in an isotonic glucose solution
INDICATION Cardiovascular
DEVELOPMENT STAGE ?
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!


spacer

• View the DATABASE results for 'Clariscan™' (6).Open this link in a new window

MRI Resources 
General - MRI Technician and Technologist Career - Research Labs - Cochlear Implant - Pathology - Chemistry
 
     1 - 5 (of 15)     next
Result Pages : [1]  [2 3]
 Random Page
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?  



In 2075 (after about 100 years of ...) the MRI scan will be :
obsolete 
done with handheld probe 
done at home (app, ...) 
a 3 second walk through 
daily done 
replaced by something much ... 

Look
      Ups





Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • US-TIP • The-Medical-Market
Copyright © 2003 - 2016 SoftWays. All rights reserved. [ 24 February 2017]
Terms of Use | Privacy Policy | Advertising
 [last update: 2017-02-21 00:45:00]